← Leaderboards
Frederic M. Waldman
University Of California San Francisco
$7,639,095
Attributed
$7,639,095
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,529,050 · 7
By mechanism
R01$6,742,592 · 4
P01$1,122,973 · 2
P30$663,485 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Frank Patrick McCormick$56,513,144
- Donna G Albertson$14,886,713
- Stanley P L Leong$101,641
- Colin C Collins$2,944,307
- Andrew T Parsa$4,652,464
Others in their field
Top investigators on “Neoplasm /Cancer Genetics”
- Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
- Charles A Coltman · Southwest Oncology Group$46,831,444
- Samuel A Wells · Duke University$32,148,803
- David Sidransky · Johns Hopkins University$27,906,864
- Brian E Henderson · University Of Southern California$27,493,155
- Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365
Research focus
Neoplasm /Cancer GeneticsNeoplastic ProcessComparative Genomic HybridizationTumorGenomicsBaseGeneticGenetic MarkersNeoplasm /Cancer ChemotherapyHuman SubjectTissuesClinical ResearchAntibodiesResourcesCancer RiskCollaborationsGenomeHuman TissueMalignant NeoplasmsBladder NeoplasmGenesRisk FactorsMicroarray TechnologyMolecular
Grant awards (29)
IMMUNOHISTOCHEMISTRY AND MOLECULAR PATHOLOGY$137,346
P30 · FY2011 · CA · contact PI
IMMUNOHISTOCHEMISTRY AND MOLECULAR PATHOLOGY$136,066
P30 · FY2010 · CA · contact PI
Predictive Markers in Metastatic Renal Cancer$1
R01 · FY2010 · CA · contact PI
Predictive Markers in Metastatic Renal Cancer$644,954
R01 · FY2009 · CA · contact PI
Bladder Cancer Risk and Genomic Alterations$353,430
R01 · FY2009 · CA · contact PI
IMMUNOHISTOCHEMISTRY AND MOLECULAR PATHOLOGY$135,355
P30 · FY2009 · CA · contact PI
Predictive Markers in Metastatic Renal Cancer$713,221
R01 · FY2008 · CA · contact PI
Bladder Cancer Risk and Genomic Alterations$345,229
R01 · FY2008 · CA · contact PI
IMMUNOHISTOCHEMISTRY AND MOLECULAR PATHOLOGY$137,368
P30 · FY2008 · CA · contact PI
Bladder Cancer Risk and Genomic Alterations$378,019
R01 · FY2007 · CA · contact PI
Renal cancer genomic alterations and environmental risk(RMI)$278,096
R01 · FY2007 · CA · contact PI
IMMUNOHISTOCHEMISTRY AND MOLECULAR PATHOLOGY$117,350
P30 · FY2007 · CA · contact PI
Renal cancer genomic alterations and environmental risk$286,402
R01 · FY2006 · CA · contact PI
Genomic Markers of Colon Cancer Progression$306,063
R01 · FY2005 · CA
Renal cancer genomic alterations-environmental risk(RMI)$293,295
R01 · FY2005 · CA
GENETIC MARKERS OF BLADDER CANCER PROGRESSION$261,658
R01 · FY2005 · CA
Genomic Markers of Colon Cancer Progression$306,063
R01 · FY2004 · CA
Renal cancer genomic alterations and environmental risk$296,086
R01 · FY2004 · CA
GENETIC MARKERS OF BLADDER CANCER PROGRESSION$261,658
R01 · FY2004 · CA
Genomic Markers of Colon Cancer Progression$306,063
R01 · FY2003 · CA
Renal cancer genomic alterations and environmental risk$303,379
R01 · FY2003 · CA
GENETIC MARKERS OF BLADDER CANCER PROGRESSION$261,658
R01 · FY2003 · CA
Genomic Markers of Colon Cancer Progression$306,063
R01 · FY2002 · CA
GENETIC MARKERS OF BLADDER CANCER PROGRESSION$261,658
R01 · FY2002 · CA
Core--Immunohistochemistry/molecular pathology facility$0
P30 · FY2002 · CA
Genomic Markers of Colon Cancer Progression$306,063
R01 · FY2001 · CA
GENETIC MARKERS OF BLADDER CANCER PROGRESSION$273,533
R01 · FY2001 · CA
MOLECULAR/CELLULAR PREDICTORS OF BREAST CANCER PROGNOSIS$889,955
P01 · FY2000 · CA
BREAST CANCER MOLECULAR CYTOGENETICS$233,018
P01 · FY2000 · CA